Literature DB >> 12512158

Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice.

J Cooke1, M Kubin, T Morris, J Ribas, I Krämer, W Kämmerer, R Fornaini, A C Ballet, P P Sagnier.   

Abstract

BACKGROUND: Hospitalised patients with respiratory tract infections (RTI) frequently receive intravenous (i.v.) antibiotics followed by a short course of oral treatment.
OBJECTIVES: To observe antibiotic use in hospitals in Germany, Spain, France, Italy and the UK and the reasons for choosing the i.v. route and switching to oral treatment.
METHODS: Research pharmacists sought the opinions of physicians and senior nurses in the completion of a semi-structured questionnaire on the treatment of RTI with i.v. antibiotics. Questions focussed on antimicrobials of choice, reasons for choosing i.v., reasons for changing to oral administration, and duration of treatment.
RESULTS: This study recruited 796 patients with RTI, usually pneumonia. Prescribing patterns varied widely between the five hospitals. Accepted clinical criteria were only commonly cited in Germany, Spain and the UK as reasons for choosing the i.v. route at the beginning of the study. These were more commonly cited at the time of switch, although other criteria such as improved condition, were other significant reasons. The mean duration of i.v. treatment ranged from 4 days in the UK to 10 days in Italy, where most patients received the full course of treatment by the i.v. route. Unlike the other hospitals studied, the few patients in Italy who were switched to another form of treatment were as likely to receive intramuscular as oral administration (13% and 11%, respectively).
CONCLUSIONS: The practice of and reasons for prescribing i.v. antibiotics varied in the hospitals studied. Objective clinical criteria were inconsistently cited as reasons for administering i.v. antibiotics and in general these reasons were unrelated to those given for the switch from i.v. to oral administration. In order for guidelines for switching from i.v. to oral antimicrobials to be routinely employed, explicit physiological criteria need to be recorded in a routine fashion. Closer co-operation between pharmacists and physicians may help in developing and implementing guidelines at a local level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512158     DOI: 10.1023/a:1021522226178

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  19 in total

1.  Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital.

Authors:  L Frighetto; D Nickoloff; S M Martinusen; F S Mamdani; P J Jewesson
Journal:  Ann Pharmacother       Date:  1992-11       Impact factor: 3.154

Review 2.  Pharmacoeconomics of intravenous drug administration.

Authors:  S E Parker; P G Davey
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

3.  Intravenous filters and phlebitis.

Authors:  P Francombe
Journal:  Nurs Times       Date:  1988 Jun 29-Jul 5

4.  Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.

Authors:  S Ahkee; S Smith; D Newman; W Ritter; J Burke; J A Ramirez
Journal:  Pharmacotherapy       Date:  1997 May-Jun       Impact factor: 4.705

5.  Sequential antibiotic therapy: Effective cost management and patient care.

Authors:  L A Mandell; M G Bergeron; M J Gribble; P J Jewesson; D E Low; T J Marrie; L E Nicolle
Journal:  Can J Infect Dis       Date:  1995-11

6.  Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.

Authors:  J A Ramirez; S Vargas; G W Ritter; M E Brier; A Wright; S Smith; D Newman; J Burke; M Mushtaq; A Huang
Journal:  Arch Intern Med       Date:  1999-11-08

Review 7.  Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  A Ikeda; K Nishimura; T Izumi
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

8.  Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.

Authors:  J Lorenz
Journal:  Chemotherapy       Date:  1998-09       Impact factor: 2.544

9.  The management of infections and antibiotic therapy: a European survey.

Authors:  G A Halls
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

Review 10.  Community-acquired pneumonia. Cost-effective antimicrobial therapy.

Authors:  B A Cunha
Journal:  Postgrad Med       Date:  1996-01       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.